Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
JAMA Surg. 2019 May 1;154(5):413-420. doi: 10.1001/jamasurg.2018.5248.
Adhesive small-bowel obstruction (aSBO) is a potentially chronic, recurring surgical illness. Although guidelines suggest trials of nonoperative management, the long-term association of this approach with recurrence is poorly understood.
To compare the incidence of recurrence of aSBO in patients undergoing operative management at their first admission compared with nonoperative management.
DESIGN, SETTING, AND PARTICIPANTS: This longitudinal, propensity-matched, retrospective cohort study used health administrative data for the province of Ontario, Canada, for patients treated from April 1, 2005, through March 31, 2014. The study population included adults aged 18 to 80 years who were admitted for their first episode of aSBO. Patients with nonadhesive causes of SBO were excluded. A total of 27 904 patients were included and matched 1:1 by their propensity to undergo surgery. Factors used to calculate propensity included patient age, sex, comorbidity burden, socioeconomic status, and rurality of home residence. Data were analyzed from September 10, 2017, through October 4, 2018.
Operative vs nonoperative management for aSBO.
The primary outcome was the rate of recurrence of aSBO among those with operative vs nonoperative management. Time-to-event analyses were used to estimate hazard ratios of recurrence while accounting for the competing risk of death.
Of 27 904 patients admitted with their first episode of aSBO, 6186 (22.2%) underwent operative management. Mean (SD) patient age was 61.2 (13.6) years, and 51.1% (14 228 of 27 904) were female. Patients undergoing operative management were younger (mean [SD] age, 60.2 [14.3] vs 61.5 [13.4] years) with fewer comorbidities (low burden, 382 [6.2%] vs 912 [4.2%]). After matching, those with operative management had a lower risk of recurrence (13.0% vs 21.3%; hazard ratio, 0.62; 95% CI, 0.56-0.68; P < .001). The 5-year probability of experiencing another recurrence increased with each episode until surgical intervention, at which point the risk of subsequent recurrence decreased by approximately 50%.
According to this study, operative management of the first episode of aSBO is associated with significantly reduced risk of recurrence. Guidelines advocating trials of nonoperative management for aSBO may assume that surgery increases the risk of recurrence putatively through the formation of additional adhesions. The long-term risk of recurrence of aSBO should be considered in the management of this patient population.
黏连性小肠梗阻(aSBO)是一种潜在的慢性、复发性手术性疾病。尽管指南建议尝试非手术治疗,但这种方法与复发的长期关联尚未得到很好的理解。
比较初次入院时接受手术治疗与非手术治疗的 aSBO 患者的复发发生率。
设计、环境和参与者:这项纵向、倾向匹配、回顾性队列研究使用了加拿大安大略省的健康管理数据,研究对象为 2005 年 4 月 1 日至 2014 年 3 月 31 日期间首次出现 aSBO 的患者。研究人群包括年龄在 18 至 80 岁之间、因 aSBO 接受治疗的成年人。排除非黏连性 SBO 患者。共有 27904 例患者被纳入,并根据手术倾向进行 1:1 匹配。用于计算倾向的因素包括患者年龄、性别、合并症负担、社会经济状况和家庭住址的农村程度。数据于 2017 年 9 月 10 日至 2018 年 10 月 4 日进行分析。
aSBO 的手术与非手术治疗。
主要结局是手术与非手术治疗 aSBO 的患者复发率。使用时间事件分析来估计复发的风险比,同时考虑到死亡的竞争风险。
在因首次出现 aSBO 而入院的 27904 例患者中,6186 例(22.2%)接受了手术治疗。患者的平均(SD)年龄为 61.2(13.6)岁,51.1%(14228 例)为女性。接受手术治疗的患者年龄较小(平均[SD]年龄为 60.2[14.3]岁 vs 61.5[13.4]岁),合并症较少(低负担为 382 例[6.2%] vs 912 例[4.2%])。匹配后,手术治疗组的复发风险较低(13.0% vs 21.3%;风险比,0.62;95%CI,0.56-0.68;P<0.001)。每次发作后,再次出现发作的 5 年概率都会增加,直到进行手术干预,此时后续复发的风险降低约 50%。
根据这项研究,初次出现 aSBO 时进行手术治疗与复发风险显著降低相关。建议对 aSBO 进行非手术治疗试验的指南可能假设手术会通过形成额外的粘连而增加复发的风险。在管理这类患者人群时,应考虑到 aSBO 复发的长期风险。